Jan. 12, 2026, San Francisco. Issued from the J.P. Morgan Healthcare ConferenceWARREN, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Tevogen ...

Cellares and City of Hope are partnering to evaluate automating CAR T manufacturing for glioblastoma brain cancer therapy.

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Scott Drutman Incoming Chief Medical Officer of Enara Bio Boehringer Ingelheim exercises option to license additional Dark ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key ...

T cell development is a tightly regulated process that transforms immature thymocytes into mature T cells with distinct functionalities. In the thymus, precursor cells undergo a series of selection ...

At the recent American Society of Hematology annual meeting, researchers presented preclinical data examining how ...